Drugs and Therapy Perspectives最新文献

筛选
英文 中文
Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States 美国非酒精性脂肪肝患者多药、患者自述症状和生活质量之间的关系
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-11-01 DOI: 10.1007/s40267-022-00957-z
M. Alrasheed, Jef J. Guo, A. C. Lin, P. Wigle, Angelica M. Hardee, A. Hincapie
{"title":"Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States","authors":"M. Alrasheed, Jef J. Guo, A. C. Lin, P. Wigle, Angelica M. Hardee, A. Hincapie","doi":"10.1007/s40267-022-00957-z","DOIUrl":"https://doi.org/10.1007/s40267-022-00957-z","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"490 - 498"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42680958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution 更正:大型三级学术医疗机构非瓣膜性房颤患者阿哌沙班剂量不适当的患病率和预测因素
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-10-31 DOI: 10.1007/s40267-022-00959-x
H. Badreldin, Lamya Alreshoud, Renad Altoukhi, Senthilvel Vasudevan, Wesam Ismail, M. S. Mohamed
{"title":"Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution","authors":"H. Badreldin, Lamya Alreshoud, Renad Altoukhi, Senthilvel Vasudevan, Wesam Ismail, M. S. Mohamed","doi":"10.1007/s40267-022-00959-x","DOIUrl":"https://doi.org/10.1007/s40267-022-00959-x","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"499 - 499"},"PeriodicalIF":1.2,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45817190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approach the treatment of acne in transgender patients with sensitivity and awareness 探讨变性人痤疮治疗的敏感性和认识
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-10-25 DOI: 10.1007/s40267-022-00949-z
Yvette N. Lamb
{"title":"Approach the treatment of acne in transgender patients with sensitivity and awareness","authors":"Yvette N. Lamb","doi":"10.1007/s40267-022-00949-z","DOIUrl":"https://doi.org/10.1007/s40267-022-00949-z","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"472 - 477"},"PeriodicalIF":1.2,"publicationDate":"2022-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46653961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting toxic forms of α-synuclein with immunotherapy could alter the progression of Parkinson’s disease 免疫疗法靶向α-突触核蛋白的毒性形式可以改变帕金森病的进展
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-10-18 DOI: 10.1007/s40267-022-00950-6
J. Paik
{"title":"Targeting toxic forms of α-synuclein with immunotherapy could alter the progression of Parkinson’s disease","authors":"J. Paik","doi":"10.1007/s40267-022-00950-6","DOIUrl":"https://doi.org/10.1007/s40267-022-00950-6","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"467 - 471"},"PeriodicalIF":1.2,"publicationDate":"2022-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44317640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use 修正:异苦螨灵治疗与慢性肾脏疾病相关的瘙痒:其使用概况
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-10-01 DOI: 10.1007/s40267-022-00953-3
Yvette N. Lamb
{"title":"Correction to: Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use","authors":"Yvette N. Lamb","doi":"10.1007/s40267-022-00953-3","DOIUrl":"https://doi.org/10.1007/s40267-022-00953-3","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"431 - 431"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48840187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Completion Rates and Hepatotoxicity of Isoniazid Preventive Therapy Among Children Living with HIV/AIDS: Findings and Implications in Northwestern Nigeria 尼日利亚西北部儿童艾滋病毒/艾滋病预防性治疗的完成率和肝毒性:研究结果和意义
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-10-01 DOI: 10.1007/s40267-022-00946-2
I. Ogunyinka, Y. Wada, Ta Bolajoko, Yusuf Tahir, K. Oshikoya
{"title":"Completion Rates and Hepatotoxicity of Isoniazid Preventive Therapy Among Children Living with HIV/AIDS: Findings and Implications in Northwestern Nigeria","authors":"I. Ogunyinka, Y. Wada, Ta Bolajoko, Yusuf Tahir, K. Oshikoya","doi":"10.1007/s40267-022-00946-2","DOIUrl":"https://doi.org/10.1007/s40267-022-00946-2","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"455 - 466"},"PeriodicalIF":1.2,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44058814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vosoritide in achondroplasia: a profile of its use Vosoritide在软骨发育不全中的应用概况
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-09-28 DOI: 10.1007/s40267-022-00942-6
Young-A. Heo
{"title":"Vosoritide in achondroplasia: a profile of its use","authors":"Young-A. Heo","doi":"10.1007/s40267-022-00942-6","DOIUrl":"https://doi.org/10.1007/s40267-022-00942-6","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"417 - 422"},"PeriodicalIF":1.2,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41689155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consider old and new approaches when treating dyslipidaemia 在治疗血脂异常时考虑新旧方法
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-09-26 DOI: 10.1007/s40267-022-00947-1
Esther S. Kim, Arnold Lee
{"title":"Consider old and new approaches when treating dyslipidaemia","authors":"Esther S. Kim, Arnold Lee","doi":"10.1007/s40267-022-00947-1","DOIUrl":"https://doi.org/10.1007/s40267-022-00947-1","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"437 - 442"},"PeriodicalIF":1.2,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46651168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use Difelikefalin治疗与慢性肾脏疾病相关的瘙痒症:应用概况
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-09-14 DOI: 10.1007/s40267-022-00945-3
Yvette N. Lamb
{"title":"Difelikefalin in pruritus associated with chronic kidney disease: a profile of its use","authors":"Yvette N. Lamb","doi":"10.1007/s40267-022-00945-3","DOIUrl":"https://doi.org/10.1007/s40267-022-00945-3","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"423 - 430"},"PeriodicalIF":1.2,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47660563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consider new topical treatments alongside existing options when treating acne vulgaris 在治疗寻常痤疮时,考虑新的局部治疗方法和现有的选择
IF 1.2
Drugs and Therapy Perspectives Pub Date : 2022-09-13 DOI: 10.1007/s40267-022-00941-7
Tina Nie, Arnold Lee
{"title":"Consider new topical treatments alongside existing options when treating acne vulgaris","authors":"Tina Nie, Arnold Lee","doi":"10.1007/s40267-022-00941-7","DOIUrl":"https://doi.org/10.1007/s40267-022-00941-7","url":null,"abstract":"","PeriodicalId":36009,"journal":{"name":"Drugs and Therapy Perspectives","volume":"38 1","pages":"432 - 436"},"PeriodicalIF":1.2,"publicationDate":"2022-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41884321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信